New search | Conferencedetail
Print view
 
 

Microbiome Drug Development Summit Europe Paris 2018

evvnt Platform / evvnt
Conference themes
Situated at the heart of therapeutic R&D, the Microbiome Drug Development Summit kick starts 2018, once again to help large pharma, biotech and academic institutions accelerate the discovery, clinical development of safe, effective and commercially scalable microbiome therapeutics across a broad range of disease indications.
Professional congress organizer (PCO)
HansonWadeLtd
Notes
Speakers: Outi Vaarala (VP Head of Translational Biology at AstraZeneca), Olga Danilchanka (Microbiome Lead; Exploratory Science Center (ESC) at Merck), Laurence Zitvogel (Professor at Institut Gustave Roussy) and many more.
 

Enquiries and Registration:

https://go.evvnt.com/160058-1
Mr. Alex Puttick
 
Categories
General Medicine
Languages
English
Congress fees
EUR 2.199,00
(Prices: Industry Conference Only: EUR 2199, Academic Conference Only: EUR 1699.)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Ärzte der WeltAnästhesie in Entwicklungsländern e. V.FFG - 7. EU-RahmenprogrammnewTreeÖsterreichische Akademie der ÄrzteÖsterreichische Gesellschaft für Public HealthHilfswerk AustriaOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation

Facebook

Give us your professional opinion

Start survey

Start survey